English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  51412960    線上人數 :  806
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"jiaang wt"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 16-65 / 86 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
國家衛生研究院 2020-10-16 Potent and orally active purine-based fetal hemoglobin inducers for treating Beta-thalassemia and sickle cell disease Lai, ZS;Yeh, TK;Chou, YC;Hsu, T;Lu, CT;Kung, FC;Hsieh, MY;Lin, CH;Chen, CT;James Shen, CK;Jiaang, WT
國家衛生研究院 2019-12 Identification of a multitargeted tyrosine kinase inhibitor for the treatment of gastrointestinal stromal tumors and acute myeloid leukemia Lin, WH;Wu, SY;Yeh, TK;Chen, CT;Song, JS;Shiao, HY;Kuo, CC;Hsu, T;Lu, CT;Wang, PC;Wu, TS;Peng, YH;Lin, HY;Chen, CP;Weng, YL;Kung, FC;Wu, MH;Su, YC;Huang, KW;Chou, LH;Hsueh, CC;Yen, KJ;Kuo, PC;Huang, CL;Chen, LT;Shih, C;Tsai, HJ;Jiaang, WT
國家衛生研究院 2019-11-12 Composto Tsai, TY;Hsu, T;Jiaang, WT;Chao, YS
國家衛生研究院 2019-07 Use of integrated genomic analyses in patient-derived tumor model to discover new clinical indications for the multikinase inhibitor drug candidate, DBPR216 Kuo, CC;Jiaang, WT;Ou, JJ;Chen, CT;Hsu, SC;Shih, C;Lin, LM;Sun, M;Wang, YH;Huang, ZT;Chang, JY;Ueng, SH
國家衛生研究院 2019-05-28 Identification of novel anti-liver cancer small molecules with better therapeutic index than sorafenib via zebrafish drug screening platform Lin, HS;Huang, YL;Wang, YS;Hsiao, E;Hsu, TA;Shiao, HY;Jiaang, WT;Sampurna, BP;Lin, KH;Wu, MS;Lai, GM;Yuh, CH
國家衛生研究院 2019-05-28 Aminothiazole compounds as protein kinase inhibitors Jiaang, WT;Shih, C;Tsai, HJ
國家衛生研究院 2019-04-10 Discovery of Conformational Control Inhibitors Switching off the Activated c-KIT and Targeting a Broad Range of Clinically Relevant c-KIT Mutants Wu, TS;Lin, WH;Tsai, HJ;Hsueh, CC;Hsu, T;Wang, PC;Lin, HY;Peng, YH;Lu, CT;Lee, LC;Tu, CH;Kung, FC;Shiao, HY;Yeh, TK;Song, JS;Chang, JY;Su, YC;Chen, LT;Chen, CT;Jiaang, WT;Wu, SY
國家衛生研究院 2018-08-24 BPR1J373, a novel multi-targeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor Tsai, HJ;Jiaang, WT;Shih, NY;Fletcher, JA;Lin, MJ;Yang, MY;Chen, CT;Hsu, TJ;Wu, CC;Lin, HY;Chen, LT
國家衛生研究院 2018-08-24 BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor Tsai, HJ;Jiaang, WT;Shih, NY;Fletcher, JA;Lin, MJ;Yang, MY;Chen, CT;Hsu, TAJ;Wu, CC;Lin, HY;Chen, LT
國家衛生研究院 2018-08-14 Aminothiazole compounds Jiaang, WT;Hsu, T
國家衛生研究院 2017-03-21 Pyrrolidine derivatives Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T
國家衛生研究院 2016-12 Novel cKIT kinase inhibitor, BPRCKJ001, as an advanced therapeutic candidate for GIST Shiao, HY;Tsai, HJ;Lin, WH;Tsu, TA;Yeh, TK;Chen, CT;Jiaang, WT
國家衛生研究院 2016-10 BPR1J373, an oral multiple tyrosine kinase inhibitor, targets c-KIT for the treatment of c-KIT driven myeloid leukemia Chen, LT;Chen, CT;Jiaang, WT;Chen, TY;Butterfield, JH;Shih, NY;Hsu, JT;Lin, HY;Lin, SF;Tsai, HJ
國家衛生研究院 2016-08-30 Pyrrolidine derivatives Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T
國家衛生研究院 2016-04-12 Pyrazolylamine derivatives reveal the conformational switching between type I and type II binding modes of Anaplastic Lymphoma Kinase (ALK) Tu, CH;Lin, WH;Peng, YH;Hsu, T;Wu, JS;Chang, CY;Lu, CT;Lyu, PC;Shih, C;Jiaang, WT;Wu, SY
國家衛生研究院 2016-02-09 Pyrazole compounds and thiazole compounds as protein kinases inhibitors Jiaang, WT;Hsu, TA;Lin, WH;Chao, YS
國家衛生研究院 2015-11-13 Pyrrolidine derivatives Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T
國家衛生研究院 2015-07 Identification of a potent 5-phenyl-thiazol-2-ylamine-based inhibitor of FLT3 with activity against drug resistance-conferring point mutations Chen, CT;Hsu, JTA;Lin, WH;Lu, CT;Yen, SC;Hsu, T;Huang, YL;Song, JS;Chen, CH;Chou, LH;Yen, KJ;Chen, CP;Kuo, PC;Huang, CL;Eugene Liu, H;Chao, YS;Yeh, TK;Jiaang, WT
國家衛生研究院 2014-08-01 Pyrrolidine derivatives Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T
國家衛生研究院 2014-05-12 Pyrrolidine derivatives Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T
國家衛生研究院 2014-05-08 Pyrrolidine derivatives Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T
國家衛生研究院 2014-04-25 Pyrrolidine derivatives Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T
國家衛生研究院 2014-04-21 作為蛋白質激酶抑制劑之吡唑化合物及噻唑化合物、其醫藥組成物及用途 Jiaang, WT;Hsu, TA;Lin, WH;Chao, YS
國家衛生研究院 2014-02-19 Pyrrolidine derivatives Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T
國家衛生研究院 2014-02 Fibroblast activation protein (FAP) is essential for the migration of bone marrow mesenchymal stem cells through RhoA activation Chung, KM;Hsu, SC;Chu, YR;Lin, MY;Jiaang, WT;Chen, RH;Chen, X
國家衛生研究院 2014-01-08 Evaluation of the antitumor effects of BPR1J-340, a potent and selective FLT3 inhibitor, alone or in combination with an HDAC inhibitor, vorinostat, in AML cancer Lin, WH;Yeh, TK;Jiaang, WT;Yen, KJ;Chen, CH;Huang, CT;Yen, SC;Hsieh, SY;Chou, LH;Chen, CP;Chiu, CH;Kao, LC;Chao, YS;Chen, CT;Hsu, JTA
國家衛生研究院 2014-01 A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B/NS3 protease Yang, CC;Hu, HS;Wu, RH;Wu, SH;Lee, SJ;Jiaang, WT;Chern, JH;Huang, ZS;Wu, HN;Chang, CM;Yueh, A
國家衛生研究院 2013-12-18 吡咯烷化合物 Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T
國家衛生研究院 2013-09-27 Pyrrolidine derivatives Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T
國家衛生研究院 2013-06-28 Optimization of ligand and lipophilic efficiency to identify an in vivo active furano-pyrimidine aurora kinase inhibitor Shiao, HY;Coumar, MS;Chang, CW;Ke, YY;Chi, YH;Chu, CY;Sun, HY;Chen, CH;Lin, WH;Fung, KS;Kuo, PC;Huang, CT;Chang, KY;Lu, CT;Hsu, JT;Chen, CT;Jiaang, WT;Chao, YS;Hsieh, HP
國家衛生研究院 2013-06 Discovery of 3-phenyl-1H-5-pyrazolylamine derivatives containing a urea pharmacophore as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3) Lin, WH;Hsu, JTA;Hsieh, SY;Chen, CT;Song, JS;Yen, SC;Hsu, T;Lu, CT;Chen, CH;Chou, LH;Yang, YN;Chiu, CH;Chen, CP;Tseng, YJ;Yen, KJ;Yeh, CF;Chao, YS;Yeh, TK;Jiaang, WT
國家衛生研究院 2013-04-30 Pyrrolidine derivatives Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T
國家衛生研究院 2013-02-11 吡咯啉啶化合物 Jiaang, WT;Tsai, TY;Hsu, T;Chao, YS
國家衛生研究院 2013-02-11 吡咯啶化合物 Jiaang, WT;Chen, X
國家衛生研究院 2013-02 Resistance studies of a di-thiazol analogue, DBPR110, as a potential hepatitis C virus NS5A inhibitor in replicon systems Lin, HM;Wang, JC;Hu, HS;Wu, PS;Wang, WH;Wu, SY;Yang, CC;Yeh, TK;Hsu, TA;Jiaang, WT;Chao, YS;Chern, JH;Yueh, A
國家衛生研究院 2012-06-15 Pyrrolidine derivatives Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T
國家衛生研究院 2012-06-07 3-Phenyl-1H-5-pyrazolylamine-based derivatives as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3) Hsu, JT;Yeh, TK;Yen, SC;Chen, CT;Hsieh, SY;Hsu, T;Lu, CT;Chen, CH;Chou, LH;Chiu, CH;Chang, YI;Tseng, YJ;Yen, KR;Chao, YS;Lin, WH;Jiaang, WT
國家衛生研究院 2012-06-05 Pyrrolidine derivatives Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T
國家衛生研究院 2012-04-21 吡咯啉啶化合物 Jiaang, WT;Chao, YS;Hsieh, HP
國家衛生研究院 2012-01-17 Pyrrolidine compounds Jiaang, WT;Chen, X;Wu, SY;Hsieh, HP;Chao, YS
國家衛生研究院 2012-01 Resistance analysis and characterization of a thiazole analogue, BP008, as a potent hepatitis C virus NS5A inhibitor Lin, HM;Wang, JC;Hu, HS;Wu, PS;Yang, CC;Wu, CP;Pu, SY;Hsu, TA;Jiaang, WT;Chao, YS;Chern, JH;Yeh, TK;Yueh, A
國家衛生研究院 2012-01 BPR1J-097, a novel FLT3 kinase inhibitor, exerts potent inhibitory activity against AML Lin, WH;Jiaang, WT;Chen, CW;Yen, KJ;Hsieh, SY;Yen, SC;Chen, CP;Chang, KY;Chang, CY;Chang, TY;Huang, YL;Yeh, TK;Chao, YS;Chen, CT;Hsu, JT
國家衛生研究院 2011-12-06 Pyrrolidine compounds Jiaang, WT;Chen, X
國家衛生研究院 2011-09-20 Pyrrolidine derivatives Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T
國家衛生研究院 2011-07 Discovery and evaluation of 3-phenyl-1H-5-pyrazolylamine-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3) Lin, WH;Hsieh, SY;Yen, SC;Chen, CT;Yeh, TK;Hsu, T;Lu, CT;Chen, CP;Chen, CW;Chou, LH;Huang, YL;Cheng, AH;Chang, YI;Tseng, YJ;Yen, KR;Chao, YS;Hsu, JT;Jiaang, WT
國家衛生研究院 2011-06 Cleavage-site specificity of prolyl endopeptidase FAP investigated with a full-length protein substrate Huang, CH;Suen, CS;Lin, CT;Chien, CH;Lee, HY;Chung, KM;Tsai, TY;Jiaang, WT;Hwang, MJ;Chen, X
國家衛生研究院 2011-06 Current advances and therapeutic potential of agents targeting dipeptidyl peptidases-IV, -II, 8/9 and fibroblast activation protein Chen, SJ;Jiaang, WT
國家衛生研究院 2011-05-25 Pyrrolidine derivatives Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T
國家衛生研究院 2011-02 Synthesis of 3,3-dimethylglutamic acid derivatives as DPP-IV inhibitors and evaluation of their chemical stability Hsu, T;Tsai, TY;Tseng, YJ;Chiou, MC;Lu, CT;Chao, YS;Jiaang, WT
國家衛生研究院 2010-10-06 吡咯烷化合物 Jiaang, WT;Chen, X;Wu, SY;Hsieh, HP;Chao, YS

顯示項目 16-65 / 86 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目